NantHealth (NASDAQ: NH) and Evolent Health (NYSE:EVH) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations.
Insider and Institutional Ownership
7.1% of NantHealth shares are held by institutional investors. Comparatively, 95.4% of Evolent Health shares are held by institutional investors. 58.0% of NantHealth shares are held by company insiders. Comparatively, 8.8% of Evolent Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Valuation & Earnings
This table compares NantHealth and Evolent Health’s top-line revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Evolent Health has higher revenue and earnings than NantHealth. Evolent Health is trading at a lower price-to-earnings ratio than NantHealth, indicating that it is currently the more affordable of the two stocks.
This is a summary of current ratings for NantHealth and Evolent Health, as reported by MarketBeat.
||Strong Buy Ratings
NantHealth currently has a consensus price target of $9.00, indicating a potential upside of 139.36%. Evolent Health has a consensus price target of $28.00, indicating a potential upside of 91.78%. Given NantHealth’s higher probable upside, research analysts plainly believe NantHealth is more favorable than Evolent Health.
This table compares NantHealth and Evolent Health’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Evolent Health beats NantHealth on 9 of the 12 factors compared between the two stocks.
NantHealth Company Profile
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.
Evolent Health Company Profile
Evolent Health, Inc. is engaged in healthcare delivery and payment. The Company supports health systems and physician organizations in their migration toward value-based care and population health management. The Company provides an end-to-end, technology-enabled services platform for providers. The Company’s platform, powered by its technology, processes and integrated services, enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to payment models that reward value-based payment models. The Company’s services include providing its customers, with a population management platform, integrated data and analytics capabilities, pharmacy benefit management (PBM) services and comprehensive health plan administration services. Its value-based operations are empowered and supported by Identifi. Identifi is the Company’s technology platform that aggregates and analyzes data, manages care workflows and engages patients.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.